Alina Berriolo-Riedinger

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger et al. · Blood · 2011 · 301 citations

Medicine, Oncology, Radiology +13

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax

Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 254 citations

Medicine, Oncology, Radiology +11

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

Myriam Sasanelli, Michel Meignan, Corinne Haïoun et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 239 citations

Medicine, Oncology, Medical Oncology +5

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Olivier Casasnovas, Réda Bouabdallah, Pauline Brice et al. · The Lancet Oncology · 2019 · 209 citations · Full text

Medicine, Oncology, Radiation Oncology +8